Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.061,12
-5,92%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Arcellx Inc (ACLX) Arcellx Inc (ACLX) Notizie

Arcellx Inc

ACLX
50,02
-1,09 (-2,13%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:02:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/4/202422:00BWArcellx to Participate in the 23rd Annual Needham Virtual..
20/3/202421:00BWArcellx to Participate at the H.C. Wainwright 2nd Annual..
08/3/202400:23EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:00PRNUSArcellx to Participate at the TD Cowen 44th Annual Health..
28/2/202422:02EDGAR2Form 8-K - Current report
28/2/202422:00PRNUSArcellx Provides Fourth Quarter and Year-End 2023 Financial..
14/2/202423:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202403:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202422:19EDGAR2Form 8-K - Current report
08/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:24EDGAR2Form 144 - Report of proposed sale of securities
05/1/202402:23EDGAR2Form 144 - Report of proposed sale of securities
05/1/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/12/202300:06EDGAR2Form 144 - Report of proposed sale of securities
28/12/202322:47EDGAR2Form 8-K - Current report
19/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:33EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:16EDGAR2Form SC 13D/A - General statement of acquisition of..
14/12/202323:52EDGAR2Form 144 - Report of proposed sale of securities
12/12/202313:37EDGAR2Form 8-K - Current report
08/12/202323:16EDGAR2Form 8-K - Current report
08/12/202322:00PRNUSArcellx Announces Continued Robust Long-Term Responses from..
15/11/202314:30DJNArcellx Shares Rise Premarket on Expanded Gilead..
15/11/202312:58DJNGilead Invests Further in Arcellx, Extends Collaboration
15/11/202312:16EDGAR2Form 8-K - Current report
15/11/202312:00BWKite and Arcellx Announce Expansion in Strategic Partnership
13/11/202322:05EDGAR2Form 8-K - Current report
13/11/202322:00PRNUSArcellx Provides Third Quarter 2023 Financial Results and..
02/11/202314:13EDGAR2Form 8-K - Current report
02/11/202314:00PRNUSArcellx Announces Oral Presentation for Its CART-ddBCMA..
26/10/202322:00PRNUSArcellx to Participate in Two Upcoming Investor Conferences
14/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:06EDGAR2Form 8-K - Current report
14/8/202322:00PRNUSArcellx Announces Partial Clinical Hold Lifted on iMMagine-1..
07/8/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202322:14EDGAR2Form 144 - Report of proposed sale of securities
21/7/202322:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/7/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202319:27EDGAR2Form 144 - Report of proposed sale of securities
20/6/202312:57DJNArcellx Shares Drop After Patient Death Draws Clinical Hold..
20/6/202301:46PRNUSArcellx Announces Clinical Hold for its iMMagine-1 Phase 2..
08/5/202322:00PRNUSArcellx Provides First Quarter Financial Results
Apertura: 50,62 Min: 49,808 Max: 51,595
Chiusura: 51,11

La tua Cronologia

NASDAQ
ACLX
Arcellx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network